StockWatch
·
Pharmaceuticals
Board Meeting6 Aug 2026, 09:01 pm

Anlon Healthcare Board Meeting on Aug 11 to Discuss Financials, Capital Raise

AI Summary

Anlon Healthcare Ltd has announced a Board of Directors meeting scheduled for August 11, 2026. The primary agenda items include the consideration and approval of audited standalone and consolidated financial statements for the fiscal year ending March 31, 2026. The board will also discuss several key strategic and operational matters such as director appointments, internal and cost auditor remuneration, enhancement of authorized share capital, alteration of the Memorandum of Association, borrowing powers, creation of security on company assets, and inter-corporate investments. A significant point of discussion will be the potential issuance of equity shares on a preferential basis for the acquisition of shares in Apiqo Organics Private Limited and Bizotic Lifescience Private Limited, along with related party transactions involving these entities and Remember India Health Links Private Limited. The meeting will also cover preparations for the Annual General Meeting, including fixing the date, venue, and approving the notice and appointment of scrutinizers.

Key Highlights

  • Board meeting scheduled for August 11, 2026.
  • Approval of audited financial statements for FY26.
  • Consideration of capital raise via preferential share issuance.
  • Discussion on acquisitions of Apiqo Organics and Bizotic Lifescience.
  • Planning for the Annual General Meeting.